Haoxi Health director Liu Jia files Form 3

Haoxi Health Technology Ltd director Liu Jia has filed an initial insider ownership report on Form 3.

Accepted by SEC EDGAR 03/19/2026 - 04:58 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Haoxi Health Technology Ltd director Liu Jia has filed an initial insider ownership report on Form 3. The filing identifies Liu Jia as a director of the company and, in the provided data, shows no reported transactions, share purchases or sales, and no listed derivative positions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Haoxi Health Technology Ltd's Form 3 for Liu Jia show?

The Form 3 identifies Liu Jia as a director of Haoxi Health Technology Ltd. In the provided data, it reports no share purchases, sales, or derivative transactions, and includes no listed derivative holdings or exercise activity for this reporting person.

Are there any buy or sell transactions for Liu Jia in Haoxi Health (HAO)'s Form 3?

No buy or sell transactions are shown for Liu Jia in the provided Form 3 data. The transaction summary reports zero buy, sell, acquire, dispose, exercise, gift, tax-withholding, and restructuring counts, indicating no transactions were reported in this filing excerpt.

Does Liu Jia have any derivative positions disclosed in Haoxi Health (HAO)'s Form 3?

The provided Form 3 data lists no derivative positions for Liu Jia. The derivative summary is empty and the transaction summary shows zero derivative transactions, suggesting there are no options, warrants, or similar instruments disclosed in this particular filing excerpt.

What role does Liu Jia hold at Haoxi Health Technology Ltd according to the Form 3?

According to the Form 3 data, Liu Jia is a director of Haoxi Health Technology Ltd and is not listed as an officer or ten percent owner. The officer title field is blank, while the director flag is marked as active in the reporting information.

Does Haoxi Health (HAO)'s Form 3 for Liu Jia indicate any net share purchases or sales?

The Form 3 summary shows neutral net activity for Liu Jia, with netBuySellShares at zero and netBuySellDirection marked "neutral". This reflects that no buys, sells, or other share-changing transactions are reported in the provided data for this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Liu Jia

(Last) (First) (Middle)

ROOM 801, TOWER C, FLOOR 8

BUILDING 103, HUIZHONGLI

(Street)

CHAOYANG DISTRICT BEIJING 98110

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Haoxi Health Technology Ltd [ HAO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Jia Liu.	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)